- Telehealth Visits
Stanford Chun, MD
Pediatric PulmonologyOn this page
About me
Dr. Stanford Chun is a pediatric pulmonologist who cares for infants, children and adolescents with a wide range of respiratory conditions and breathing concerns. His special interests include cystic fibrosis, asthma and chronic lung disease. With a passion for delivering comprehensive, individualized care, he seeks to collaborate closely with families and care teams across specialties to support the best outcomes for his patients.
Chun earned his medical degree at the University of South Florida. He completed a residency in pediatrics at Rady Children's Health (formerly Children's Hospital of Orange County), an affiliate of the University of California, Irvine. He completed a fellowship in pediatric pulmonology at Children's Hospital Los Angeles.
Chun is a Bay Area native who spent the first 18 years of his life in San Francisco. After completing his medical training in Southern California, he was happy to return home to care for the community he considers his own. Outside of work, he enjoys swimming, biking, cooking, and exploring local spots and new restaurants with his family.
Education
Board Certification
- Pediatrics, American Board of Pediatrics
Residency
- Pediatrics, University of California - Irvine Medical Center
School
- MD, University of South Florida College of Medicine
Academic Title
- Health Sciences Clinical Professor
Care Keywords
Services
- Pediatric Pulmonology
Locations
Provider Research Listing
Browse clinical trials and publications by this provider
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.